MEDIUM confidence: 100% data completeness, but the composite (55) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $12.7B— | $14.1B+10.8% | $14.8B+5.4% | $15.4B+3.6% | $16.6B+8.2% |
| EPS (dil.) | $1.50— | $1.01-32.7% | $1.55+53.5% | $1.05-32.3% | $1.53+45.7% |
| Free Cash Flow | $2.4B— | $2.5B+1.6% | $848M-65.5% | $1.7B+95.3% | $1.5B-9.1% |
| Gross Margin | 55.0% | 52.1%-2.9pp | 54.5%+2.4pp | 55.6%+1.0pp | 54.2%-1.4pp |
| Operating Margin | 22.8% | 19.8%-3.0pp | 21.6%+1.8pp | 21.6%-0.0pp | 22.0%+0.4pp |
| Net Margin | 16.9% | 10.2%-6.7pp | 14.7%+4.5pp | 9.4%-5.3pp | 12.5%+3.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$839K over 180 days (1 open-market buys, 3 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $40 avg across 4 analysts.
Buy-rated share 61% → 72% over ~3 months (+11pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.54 | $0.57 | +6.1% |
| Apr 2026 | $0.37 | $0.39 | +4.7% |
| Feb 2026 | $0.59 | $0.60 | +1.9% |
| Oct 2025 | $0.54 | $0.54 | +0.6% |
| Jul 2025 | $0.49 | $0.49 | +1.0% |
| Apr 2025 | $0.38 | $0.42 | +9.8% |
| Feb 2025 | $0.57 | $0.58 | +1.6% |
| Oct 2024 | $0.51 | $0.51 | +0.0% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 6.6%/yr (revenue basis).
Base free cash flow $1.3B (avg FY2023–FY2025; latest year $1.5B) · equity value $48.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 55 for Keurig Dr Pepper Inc. suggests a neutral outlook, with the stock's short-term score slightly outpacing its long-term score. The company scores high on momentum, driven by a 32% return over the past year and a bullish moving average trend. However, its value score is dragged down by a P/E of 36.1, indicating the stock trades at a premium. Profitability metrics, such as an ROE of 5.6%, also exhibit room for improvement, contributing to the overall middling QScore.